These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 33554955

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Alpha1-antitrypsin review.
    Stockley RA.
    Clin Chest Med; 2014 Mar; 35(1):39-50. PubMed ID: 24507836
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT, Vimalanathan S.
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [Abstract] [Full Text] [Related]

  • 25. Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria.
    Bai X, Bai A, Honda JR, Eichstaedt C, Musheyev A, Feng Z, Huitt G, Harbeck R, Kosmider B, Sandhaus RA, Chan ED.
    Front Immunol; 2019 Apr; 10():1417. PubMed ID: 31293581
    [Abstract] [Full Text] [Related]

  • 26. Blocking HXA3-mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia.
    Xu S, Tan S, Romanos P, Reedy JL, Zhang Y, Mansour MK, Vyas JM, Mecsas J, Mou H, Leong JM.
    mBio; 2024 Sep 11; 15(9):e0185624. PubMed ID: 39120139
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease.
    He N, Liu X, Vegter AR, Evans TIA, Gray JS, Guo J, Moll SR, Guo LJ, Luo M, Ma N, Sun X, Liang B, Yan Z, Feng Z, Qi L, Joshi AS, Shahin W, Yi Y, Gibson-Corley KN, Hoffman EA, Wang K, Mueller C, Engelhardt JF, Rosen BH.
    JCI Insight; 2022 Mar 08; 7(5):. PubMed ID: 35104244
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
    Lee J, Lu Y, Oshins R, West J, Moneypenny CG, Han K, Brantly ML.
    Front Immunol; 2020 Mar 08; 11():574410. PubMed ID: 33329539
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout mice.
    Dolan JM, Weinberg JB, O'Brien E, Abashian A, Procario MC, Aronoff DM, Crofford LJ, Peters-Golden M, Ward L, Mancuso P.
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun 01; 310(11):L1111-20. PubMed ID: 27059285
    [Abstract] [Full Text] [Related]

  • 37. Augmentation therapy with alpha1-antitrypsin: novel perspectives.
    Sabina J, Tobias W.
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug 01; 13(2):90-8. PubMed ID: 23987997
    [Abstract] [Full Text] [Related]

  • 38. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.
    Lieberman J.
    Chest; 2000 Nov 01; 118(5):1480-5. PubMed ID: 11083705
    [Abstract] [Full Text] [Related]

  • 39. The discovery of α1-antitrypsin and its role in health and disease.
    Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T.
    Respir Med; 2011 Aug 01; 105(8):1129-39. PubMed ID: 21367592
    [Abstract] [Full Text] [Related]

  • 40. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
    Bergin DA, Hurley K, McElvaney NG, Reeves EP.
    Arch Immunol Ther Exp (Warsz); 2012 Apr 01; 60(2):81-97. PubMed ID: 22349104
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.